Nicholas Jason Singer - Net Worth and Insider Trading

Nicholas Jason Singer Net Worth

The estimated net worth of Nicholas Jason Singer is at least $419,079 dollars as of 2024-11-13. Nicholas Jason Singer is the Director of Eterna Therapeutics Inc and owns about 388,036 shares of Eterna Therapeutics Inc (ERNA) stock worth over $419,079. Details can be seen in Nicholas Jason Singer's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Nicholas Jason Singer has not made any transactions after 2022-12-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Nicholas Jason Singer

Nicholas Jason Singer Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Nicholas Jason Singer owns 3 companies in total, including Eterna Therapeutics Inc (ERNA) , OTR Acquisition Corp (OTRA) , and OTR Acquisition Corp (OTRAU) .

Click here to see the complete history of Nicholas Jason Singer’s form 4 insider trades.

Insider Ownership Summary of Nicholas Jason Singer

Ticker	Comapny	Transaction Date	Type of Owner
ERNA	Eterna Therapeutics Inc	2022-12-02	director
OTRA	OTR Acquisition Corp	2020-11-17	director & Chief Executive Officer
OTRAU	OTR Acquisition Corp	2020-11-17	director & Chief Executive Officer

Nicholas Jason Singer Latest Holdings Summary

Nicholas Jason Singer currently owns a total of 1 stock. Nicholas Jason Singer owns 388,036 shares of Eterna Therapeutics Inc (ERNA) as of December 2, 2022, with a value of $419,079.

Latest Holdings of Nicholas Jason Singer

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
ERNA	Eterna Therapeutics Inc	2022-12-02	388,036	1.08	419,079

Holding Weightings of Nicholas Jason Singer

Nicholas Jason Singer Form 4 Trading Tracker

According to the SEC Form 4 filings, Nicholas Jason Singer has made a total of 1 transactions in Eterna Therapeutics Inc (ERNA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Eterna Therapeutics Inc is the acquisition of 283,286 shares on December 2, 2022, which cost Nicholas Jason Singer around $929,178.

Insider Trading History of Nicholas Jason Singer

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Nicholas Jason Singer Trading Performance

GuruFocus tracks the stock performance after each of Nicholas Jason Singer's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Nicholas Jason Singer is 13.64%. GuruFocus also compares Nicholas Jason Singer's trading performance to market benchmark return within the same time period. The performance of stocks bought by Nicholas Jason Singer within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Nicholas Jason Singer's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Nicholas Jason Singer

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	-2.42
Relative Return to S&P 500(%)	3.28

Nicholas Jason Singer Ownership Network

Ownership Network List of Nicholas Jason Singer

No Data

Ownership Network Relation of Nicholas Jason Singer

Nicholas Jason Singer Owned Company Details

What does Eterna Therapeutics Inc do?

Who are the key executives at Eterna Therapeutics Inc?

Nicholas Jason Singer is the director of Eterna Therapeutics Inc. Other key executives at Eterna Therapeutics Inc include 10 percent owner Charles Cherington , 10 percent owner Freebird Investments Llc , and 10 percent owner Freebird Partners Lp .

Eterna Therapeutics Inc (ERNA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Eterna Therapeutics Inc (ERNA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Eterna Therapeutics Inc (ERNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Eterna Therapeutics Inc (ERNA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Eterna Therapeutics Inc Insider Transactions

No Available Data

What does OTR Acquisition Corp do?

Who are the key executives at OTR Acquisition Corp?

Nicholas Jason Singer is the director & Chief Executive Officer of OTR Acquisition Corp. Other key executives at OTR Acquisition Corp include 10 percent owner Otr Acquisition Sponsor Llc , and director & Chief Financial Officer Douglas Brian Anderson .

OTR Acquisition Corp (OTRA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of OTR Acquisition Corp (OTRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of OTR Acquisition Corp (OTRA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

OTR Acquisition Corp (OTRA)'s detailed insider trading history can be found in Insider Trading Tracker table.

OTR Acquisition Corp Insider Transactions

No Available Data

What does OTR Acquisition Corp do?

Who are the key executives at OTR Acquisition Corp?

OTR Acquisition Corp (OTRAU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of OTR Acquisition Corp (OTRAU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of OTR Acquisition Corp (OTRAU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

OTR Acquisition Corp (OTRAU)'s detailed insider trading history can be found in Insider Trading Tracker table.

OTR Acquisition Corp Insider Transactions

No Available Data

Nicholas Jason Singer Mailing Address

Above is the net worth, insider trading, and ownership report for Nicholas Jason Singer. You might contact Nicholas Jason Singer via mailing address: 1395 Brickell Avenue, Suite 800, Miami Fl 33131.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.